Common use of Booklets Clause in Contracts

Booklets. COPY OF THE SELEX PROCESS NON-CONFIDENTIAL BOOKLET (This document may also be found as “The SELEX Process – Non-Confidential” on the SELEX Package CDROM.) EXHIBIT F NEX [***] NEX [***] NEX [***] NEX [***] SELEX ARTICLES 1990 – 2001 (BIBLIOGRAPHY) SELEX – CONFIDENTIAL DESCRIPTION SELEX ARTICLE REPRINT – BOXES 1 – 16 (BIBLIOGRAPHY) SELEX PROTOCOL MANUAL VOL. 1 SELEX PROTOCOL MANUAL VOL. 2 THE SELEX PROCESS – NON-CONFIDENTIAL Portions of this Exhibit were omitted and have been filed separatelyly with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. Sixteen (16) boxes containing one or more reprints of each article from the SELEX Articles binders. (The contents of each box are listed on the file, “SELEX Article Reprint – Boxes 1-16.”) Portions of this Exhibit were omitted and have been filed separatelyly with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act.

Booklets. COPY OF THE SELEX PROCESS NON-CONFIDENTIAL BOOKLET (This document may also be found as “The SELEX Process – Non-Confidential” on the SELEX Package CDROM.) EXHIBIT F NEX [***] NEX [***] NEX [***] NEX [***] SELEX ARTICLES 1990 – 2001 (BIBLIOGRAPHY) SELEX – CONFIDENTIAL DESCRIPTION SELEX ARTICLE REPRINT – BOXES 1 – 16 (BIBLIOGRAPHY) SELEX PROTOCOL MANUAL VOL. 1 SELEX PROTOCOL MANUAL VOL. 2 THE SELEX PROCESS – NON-CONFIDENTIAL Portions of this Exhibit were omitted and have been filed separatelyly separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. Sixteen (16) boxes containing one or more reprints of each article from the SELEX Articles binders. (The contents of each box are listed on the file, “SELEX Article Reprint – Boxes 1-16.”) Portions of this Exhibit were omitted and have been filed separatelyly separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act.